The highest baseline CD4 cell counts at ART initiation in 2012 were observed among participants from Québec (median [Q1–Q3] 400 [260–506] cells/mm3), followed by BC (360 [210–520] cells/mm3) and Ontario (329 [190–420] cells/mm3) (Figure 2). The gene discussed is CD4; the disease is breast cancer.